These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 7635595

  • 21. Genetic polymorphisms of the cancer related gene and Helicobacter pylori infection in Japanese gastric cancer patients. An age and gender matched case-control study.
    Kato S, Onda M, Matsukura N, Tokunaga A, Matsuda N, Yamashita K, Shields PG.
    Cancer; 1996 Apr 15; 77(8 Suppl):1654-61. PubMed ID: 8608558
    [Abstract] [Full Text] [Related]

  • 22. Tissue and serum pepsinogen I and II in gastric cancer identified using immunohistochemistry and rapid ELISA.
    Konishi N, Matsumoto K, Hiasa Y, Kitahori Y, Hayashi I, Matsuda H.
    J Clin Pathol; 1995 Apr 15; 48(4):364-7. PubMed ID: 7615858
    [Abstract] [Full Text] [Related]

  • 23. High-risk population for gastric cancer development based on serum pepsinogen status and lifestyle factors.
    Yamaji Y, Watabe H, Yoshida H, Kawabe T, Wada R, Mitsushima T, Omata M.
    Helicobacter; 2009 Apr 15; 14(2):81-6. PubMed ID: 19298334
    [Abstract] [Full Text] [Related]

  • 24. Pepsinogens I and II in carcinoma of the stomach: an immunohistochemical study.
    Stemmermann GN, Samloff IM, Hayashi T.
    Appl Pathol; 1985 Apr 15; 3(3):159-63. PubMed ID: 3915949
    [Abstract] [Full Text] [Related]

  • 25. Clinical implications of serum pepsinogen and progastricsin in man.
    Axelsson CK.
    Scand J Clin Lab Invest Suppl; 1992 Apr 15; 210():81-96. PubMed ID: 1455183
    [Abstract] [Full Text] [Related]

  • 26. [Pepsinogen].
    Miki K.
    Nihon Rinsho; 1995 May 15; 53(5):1198-202. PubMed ID: 7602778
    [Abstract] [Full Text] [Related]

  • 27. [Evaluation on a gastric mass survey-comparison with gastric mass screening using photofluorography and that using serum pepsinogen].
    Tomooka Y.
    Nihon Koshu Eisei Zasshi; 1996 Feb 15; 43(2):118-25. PubMed ID: 8901216
    [No Abstract] [Full Text] [Related]

  • 28. The serum pepsinogen test as a predictor of gastric cancer: the Hisayama study.
    Oishi Y, Kiyohara Y, Kubo M, Tanaka K, Tanizaki Y, Ninomiya T, Doi Y, Shikata K, Yonemoto K, Shirota T, Matsumoto T, Iida M.
    Am J Epidemiol; 2006 Apr 01; 163(7):629-37. PubMed ID: 16443800
    [Abstract] [Full Text] [Related]

  • 29. Pepsinogens: physiology, pharmacology pathophysiology and exercise.
    Gritti I, Banfi G, Roi GS.
    Pharmacol Res; 2000 Mar 01; 41(3):265-81. PubMed ID: 10675278
    [Abstract] [Full Text] [Related]

  • 30. Pepsinogens, pepsins, and peptic ulcer.
    Samloff IM, Taggart RT.
    Clin Invest Med; 1987 May 01; 10(3):215-21. PubMed ID: 3113799
    [Abstract] [Full Text] [Related]

  • 31. Prospective study of the effect of gastrectomy with and without bile reflux on serum pepsinogens.
    Biemond I, Rieu PN, Jansen JB, Joosten HJ, Lamers CB.
    Digestion; 1989 May 01; 44(3):124-30. PubMed ID: 2628135
    [Abstract] [Full Text] [Related]

  • 32. Clinical application of serum pepsinogen I and II levels for mass screening to detect gastric cancer.
    Miki K, Ichinose M, Ishikawa KB, Yahagi N, Matsushima M, Kakei N, Tsukada S, Kido M, Ishihama S, Shimizu Y.
    Jpn J Cancer Res; 1993 Oct 01; 84(10):1086-90. PubMed ID: 8226283
    [Abstract] [Full Text] [Related]

  • 33. A novel tree-structured analysis for non-invasive diagnosis of gastric adenocarcinoma.
    Wu MS, Lee WC, Lin JT, Wang HP, Wang TH, Chen CJ.
    Anticancer Res; 1995 Oct 01; 15(6B):2739-43. PubMed ID: 8669856
    [Abstract] [Full Text] [Related]

  • 34. [Mass screening of stomach neoplasms by serum pepsinogen analysis].
    Miki K.
    Nihon Naika Gakkai Zasshi; 1992 May 10; 81(5):654-9. PubMed ID: 1512496
    [No Abstract] [Full Text] [Related]

  • 35. Improvement in serum pepsinogens and gastrin in long-term monitoring after eradication of Helicobacter pylori: comparison with H. pylori-negative patients.
    Ohkusa T, Miwa H, Nomura T, Asaoka D, Kurosawa A, Sakamoto N, Abe S, Hojo M, Terai T, Ogihara T, Sato N.
    Aliment Pharmacol Ther; 2004 Jul 10; 20 Suppl 1():25-32. PubMed ID: 15298602
    [Abstract] [Full Text] [Related]

  • 36. Serum gastrin and pepsinogens do not correlate with the different grades of severity of gastro-oesophageal reflux disease: a matched case-control study.
    Monkemuller K, Neumann H, Nocon M, Vieth M, Labenz J, Willich SN, Stolte M, Hocker M, Jaspersen D, Lind T, Malfertheiner P.
    Aliment Pharmacol Ther; 2008 Aug 15; 28(4):491-6. PubMed ID: 18557987
    [Abstract] [Full Text] [Related]

  • 37. [Pepsinogen I and duodenal ulcer].
    Marchese MA.
    Arq Gastroenterol; 1988 Aug 15; 25(1):37-43. PubMed ID: 3066307
    [Abstract] [Full Text] [Related]

  • 38. Enzyme-linked immunosorbent assay of serum pepsinogen I.
    Huang SC, Miki K, Hirano K, Hayashi Y, Furihata C, Shimizu A, Ichinose M, Oka H, Matsushima T, Takahashi K.
    Clin Chim Acta; 1987 Jan 15; 162(1):85-96. PubMed ID: 3802550
    [Abstract] [Full Text] [Related]

  • 39. [Effectiveness and feasibility of a strategy for increasing participation in the Japanese Stomach Cancer Examination programs by incorporating serum pepsinogen tests].
    Kurosawa M, Kikuchi S, Arisue T, Fukao A.
    Nihon Koshu Eisei Zasshi; 1998 Apr 15; 45(4):352-60. PubMed ID: 9691665
    [Abstract] [Full Text] [Related]

  • 40. [Cigarette smoking and group I pepsinogen levels. Study in a normal population].
    Germanà B, Di Mario F, Vianello F, Dotto P, Faggian D, Plebani M, Saggioro A, Naccarato R.
    G Clin Med; 1990 Apr 15; 71(8-9):493-5. PubMed ID: 2279624
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.